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Purpose: To investigate whether myopia is becoming more common across Europe and explore whether
increasing education levels, an important environmental risk factor for myopia, might explain any temporal trend.
Design: Meta-analysis of population-based, cross-sectional studies from the European Eye Epidemiology
(E3) Consortium.
Participants: The E3 Consortium is a collaborative network of epidemiological studies of common eye
diseases in adults across Europe. Refractive data were available for 61 946 participants from 15 population-based
studies performed between 1990 and 2013; participants had a range of median ages from 44 to 78 years.
Methods: Noncycloplegic refraction, year of birth, and highest educational level achieved were obtained for
all participants. Myopia was deﬁned as a mean spherical equivalent 0.75 diopters. A random-effects meta-
analysis of age-speciﬁc myopia prevalence was performed, with sequential analyses stratiﬁed by year of birth and
highest level of educational attainment.
Main Outcome Measures: Variation in age-speciﬁc myopia prevalence for differing years of birth and
educational level.
Results: There was a signiﬁcant cohort effect for increasing myopia prevalence across more recent birth
decades; age-standardized myopia prevalence increased from 17.8% (95% conﬁdence interval [CI], 17.6e18.1)
to 23.5% (95% CI, 23.2e23.7) in those born between 1910 and 1939 compared with 1940 and 1979 (P ¼ 0.03).
Education was signiﬁcantly associated with myopia; for those completing primary, secondary, and higher edu-
cation, the age-standardized prevalences were 25.4% (CI, 25.0e25.8), 29.1% (CI, 28.8e29.5), and 36.6% (CI,
36.1e37.2), respectively. Although more recent birth cohorts were more educated, this did not fully explain the
cohort effect. Compared with the reference risk of participants born in the 1920s with only primary education,
higher education or being born in the 1960s doubled the myopia prevalence ratioe2.43 (CI, 1.26e4.17) and 2.62
(CI, 1.31e5.00), respectivelydwhereas individuals born in the 1960s and completing higher education had
approximately 4 times the reference risk: a prevalence ratio of 3.76 (CI, 2.21e6.57).
Conclusions: Myopia is becoming more common in Europe; although education levels have increased and
are associated with myopia, higher education seems to be an additive rather than explanatory factor. Increasing
levels of myopia carry signiﬁcant clinical and economic implications, with more people at risk of the sight-
threatening complications associated with high myopia. Ophthalmology 2015;122:1489-1497 ª 2015 by the
American Academy of Ophthalmology. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Supplemental material is available at www.aaojournal.org.Myopia (near-sightedness) occurs when a distant object’s
image is formed anterior to the retinal plane, most commonly
as a result of an increased axial length. This results in blurred
distant vision and, unlike hyperopia, requires refractive 2015 by the American Academy of Ophthalmology
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/). Published by Elsevier Inc.correction at all ages and severity for clear focus. Myopia is
already the most common eye condition worldwide, but the
prevalence is signiﬁcantly increasing, especially in Southeast
Asia.1e3 In Europe, Australia, and the United States, the1489http://dx.doi.org/10.1016/j.ophtha.2015.03.018
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Ophthalmology Volume 122, Number 7, July 2015prevalence of myopia seems to be lower4,5; however, there is
evidence of an increasing prevalence in the United States and
elsewhere,6e8 particularly among young adults.9 This is of
concern because myopia, even when appropriately
corrected, is associated with an increased risk of sight-
threatening diseases, such as myopic maculopathy, retinal
detachment, glaucoma, and cataract.10 Myopic maculopathy
is currently untreatable and already contributes to visual
impairment in working-age adults.11 Increasing myopia
levels in Europe carry implications for public health policy
in both the provision of clinical services and the economic
sequelae from the resulting visual impairment among the
working population.
Myopia is a highly heritable trait,12,13 and to date a
number of genetic polymorphisms have been associated
with refractive error, albeit explaining only a small pro-
portion of this heritability.14,15 Environmental factors play a
key role in myopia development and must explain the recent
changes in prevalence.16 Myopia has been associated with
education, near work, urbanization, prenatal factors,
socioeconomic status, cognitive ability, season of birth,
light, and time spent outdoors.2,16e25 One of the strongest
and most replicated risk factors is educational attain-
ment,16,26 and there is some evidence of interaction between
genetic factors and education inﬂuencing the risk of
myopia.27 The increased levels of higher education over the
20th century28 might be a causative factor, or marker of a
causative factor, for increasing myopia prevalence.
The aims of this study are to identify whether myopia is
becoming more common across Europe and to examine
whether increasing levels of education explain any temporal
trend, using data from more than 60 000 participants from
the European Eye Epidemiology (E3) Consortium.
Methods
Study Population
The E3 consortium is a collaborative initiative to share and meta-
analyze epidemiologic data on common eye diseases across
Europe. Thirty-three studies are currently part of the consortium,
and a range of ophthalmic data are available on approximately
124 000 individuals from population-based and case-control
cohorts. All studies adhere to the tenets of the Declaration of
Helsinki, and relevant local ethical committee approvals with
speciﬁc study consent were obtained.
Refractive error measurements from 68 350 adults within the 15
E3 population-based studies that had data on refractive error were
included. These included population-based cross-sectional or
cohort studies, with 2 studies recruiting participants nationally and
13 studies recruiting from a local population. Further details on
each study are provided in Table 1 and the Supplementary
information (available at www.aaojournal.org). Exclusion criteria
included subjects who had cataract or refractive surgery, retinal
detachment, or other conditions, such as keratoconus, which
might inﬂuence refraction (n ¼ 6404). Data on age at refraction
and birth year were available for 61 946 individuals, with
information on education level for 60 125 subjects. Participants
were mainly middle to late age; 98% were of European descent
(where ethnicity was known), predominantly from Northern and
Western Europe; and refractive examinations were performed
from 1990 to 2013 (Table 1).1490Study Variables
Noncycloplegic refractions were performed on all individuals
using subjective refraction, autorefraction, or a combination of
focimetry with subjective refraction. Spherical equivalent was
calculated using the standard formula (spherical equivalent ¼
sphere þ [cylinder/2]). Myopia was deﬁned as 0.75 diopters.
Myopia prevalence by age was calculated, using 5- and 10-year age
bands from 15 years to 90 years. To study the impact of edu-
cation on myopia, given the variation in educational systems across
Europe, we established a simpliﬁed 3-tier level of education across
all cohorts. Primary education was deﬁned as those leaving school
before 16 years of age, secondary education was deﬁned as those
leaving education up to the age of 19 years, and higher education
was deﬁned as those leaving education at or after the age of 20
years. Those aged younger than 20 years at the time of refraction
(and therefore unable to have reached the highest education tier)
were excluded from this analysis to avoid misclassiﬁcation bias.
We investigated the evidence for a cohort effect on increasing
myopia prevalence by observing variations in myopia prevalence
within deﬁned age bands. These analyses are focused on the age
range constituting the majority of our cohort (40e80 years of age,
birth year 1910e1979, n ¼ 56 088), meaning the youngest and
oldest participants, for whom we had no comparative birth cohort,
were not considered. Prevalence between different birth cohorts
was examined, initially using decade bins (1910e1970) and sub-
sequently in 2 birth cohort groups divided by the median birth
decade (1940e1949). Finally we examined the inﬂuence of edu-
cation by examining the myopia prevalence between birth cohorts
with the additional stratiﬁcation of educational status.
Statistical Analysis
Study-speciﬁc summary data for myopia prevalence were obtained
and combined in a random-effect meta-analysis stratiﬁed by age. A
random-effects model was chosen over a ﬁxed-effects model to
allow for expected heterogeneity between studies as a result of
varying study design. Age was standardized with demographic
distribution adjustments to age-speciﬁc estimates according to the
European Standard Population 2010.29 Evidence for the presence
of a cohort effect was investigated using random-effect meta-ana-
lyses of myopia prevalence stratiﬁed by age and birth year, and
subsequently age, birth year, and educational level. Differences
between estimates of myopia prevalence were evaluated using the
analysis of variance test, proportion z tests, and prevalence ratios
(relative difference in prevalence against a deﬁned baseline). Dif-
ferences were considered signiﬁcant at P < 0.05.
Statistical analysis was performed using Stata statistical
software version 13.1 (StataCorp LP, College Station, TX).
Graphical outputs30 were obtained using Stata, Origin version 9.0
(OriginLab Corp, Northampton, MA), or ggplot2(30) in R software
(R Foundation for Statistical Computing, Vienna, Austria;
available at http://www.R-project.org).Results
In this meta-analysis of 61 946 adults, the overall myopia preva-
lence was 24.3% (95% conﬁdence interval [CI], 20.1e28.5), with
an age-standardized prevalence in Europe of 30.6% (95% CI,
30.3e30.8). Age-stratiﬁed analyses31 revealed a high prevalence in
young adults (47.2% [95% CI, 41.8e52.5] in those aged 25e29
years), which was almost double the prevalence in those of
middle to older age (27.5% [95% CI, 23.5e31.5] in those aged
55e59 years). There were no signiﬁcant differences in the
myopia prevalence by gender.31
Table 1. Description of the 15 European Eye Epidemiology Consortium Studies Included in this Meta-Analysis of Refractive Error
Study
Data
Collection
Period Study Design
Total
Participants
with
Refraction
Refraction
Method
Exclusions*
(Cataract
Surgery)
Total
Participants
Included
Median Age,
yrs (Range)
Gender, %
Female
Ethnicity, %
European (%
Unknown)
Higher
Education,
%
Crude
Myopia
Prevalence,
%
Northern Europe
1958 British Birth
Cohort, UK
2002e2003 Population-based birth
cohort (N)
2502 Autorefraction 7 (0) 2495 44 (44e46) 51.7 98.0 (9.2) 29.9 48.7
EPIC-Norfolk, UK 2004e2011 Population-based cross-
sectional study (L)
8508 Autorefraction 1110 (971) 7444 67 (48e92) 54.5 99.7 (0) 17.9 23.0
Tromsø Eye Study,
Norway
2007e2008 Population-based
cohort (L)
6565 Autorefraction 773 (700) 5792 61 (38e87) 55.9 NA (100) 32.5 19.4
TwinsUK, UK 1998e2010 National twin
cohort (N)
6245 Autorefraction 161 (61) 6095 55 (16e85) 91.2 98.2 (23.9) 22.3 31.4
Southern Europe
Thessaloniki Eye
Study, Greece
1999e2005 Cross-sectional
population-based
study (L)
2259 Subjective 316 (303) 1952 69 (60e94) 44.7 100 (0) Unknown 14.2
Western Europe
ALIENOR, France 2006e2008 Population-based
cohort (L)
951 Autorefraction 333 (318) 618 79 (73e93) 56.6 NA (100) 20.0 16.7
ERF, Netherlands 2002e2005 Family-based cross-
sectional study (L)
2708 Subjective 46 (45) 2662 49 (14e87) 55.1 100 (0) 16.9 21.2
Gutenberg Health
Study, Germany
2007e2012 Population-based
cohort (L)
14 679 Autorefraction 610 (610) 14 069 54 (35e74) 49.4 NA (100) 37.6 31.9
KORA, Germany 2004e2005 Population-based
cohort (L)
3078 Autorefraction 706 (177) 2372 55 (35e84) 50.4 100 (0) 14.7 36.1
Montrachet, France 2009e2013 Population-based
cohort (L)
1143 Autorefraction 584 (562) 576 81 (76e92) 57.5 NA (100) Unknown 19.1
Rotterdam Study I,
Netherlands
1990e1993 Population-based
cohort (L)
6748 Subjective 182 (172) 6566 68 (55e106) 59.3 98.5 (2.0) 11.6 16.4
Rotterdam Study II,
Netherlands
2000e2002 Population-based
cohort (L)
2689 Subjective 110 (110) 2579 62 (55e99) 54.8 87.8 (0.1) 22.3 21.9
Rotterdam Study III,
Netherlands
2005e2008 Population-based
cohort (L)
3624 Subjective 94 (74) 3530 56 (46e97) 56.3 NA (100) 31.4 32.5
POLA, France 1995e1997 Population-based
cohort (L)
2464 Autorefraction 157 (128) 2315 70 (60e93) 55.8 NA (100) 7.3 16.2
Mixed
EUREYE: Norway, UK,
France, Italy,
Greece, and Estonia
2000e2002 Population-based cross-
sectional survey in 7
cities (L)
4187 Autorefraction or
focimetry with
subjective
refraction
1305 (517) 2882 72 (65e95) 56.7 NA (100) 30.0 15.6
Total cohort 1990e2013 68 350 6404 (4748) 61 946 62 57.6 98.1 36.0 25.8
ALIENOR ¼ Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes Study; EPIC ¼ European Prospective Investigation into Cancer; ERF ¼ Erasmus Rucphen Family Study;
EUREYE ¼ European Eye Study; KORA ¼ Kooperative Gesundheitsforschung in der Region Augsburg; L ¼ local; N ¼ national; NA ¼ not available; POLA ¼ Pathologies Oculaires Liées à l’Age Study.
Myopia classiﬁed in those with refraction 0.75 diopters.
*Exclusions ¼ cataract surgery, refractive surgery, retinal detachment or other conditions affecting refraction.
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Figure 1. Prevalence of myopia (spherical equivalent 0.75 diopters) against age stratiﬁed by decade of birth. Individuals aged 40 to 79 years included.
Ophthalmology Volume 122, Number 7, July 2015Cohort Effect for Increasing Myopia Prevalence
There was a trend of higher myopia prevalence with more recent
birth decade across all age groups (Fig 1), although sample sizes
for some point estimates were low, resulting in wide CIs
(Table 2, available at www.aaojournal.org).
We examined the prevalence of myopia in 2 birth cohort groups
(divided by the median birth decade): those born between 1910
and 1939 (n ¼ 22 660) and those born between 1940 and 1989
(n ¼ 33 428) (Fig 2). Myopia prevalence in a variance model was
signiﬁcantly higher in the more recent birth cohort group (P ¼
0.03). Age-standardized myopia prevalence over a comparable
age range of 50 to 79 years increased from 17.8% (95% CI,
17.6e18.1) in those born in 1910e1939 to 23.5% (95% CI,
23.2e23.7) in those born in 1940e1979. In age-speciﬁc analyses,
the prevalence of myopia in those aged 50 to 59 years (at the time
of their refraction) was 22.5% (95% CI, 20.2e24.9) in those born
before 1940, compared with 29.2% (95% CI, 25.3e33.0) in those
born after 1940 (P ¼ 0.004). A similar signiﬁcant increase ofFigure 2. Prevalence of myopia (spherical equivalent 0.75 diopters) as a
conﬁdence intervals.
149215.3% (95% CI, 13.4e17.3) to 21.2% (95% CI, 18.6e23.8) was
observed in those aged 60 to 69 years (P < 0.001).Inﬂuence of Education on Myopia Risk and the
Cohort Effect
The association between education and myopia was investigated in
the 13 studies from which these data were available (n ¼ 60 125
participants). Educational level was signiﬁcantly associated with
myopia prevalence across all age strata (P < 0.0001). Overall, the
age-standardized myopia prevalence for those completing primary,
secondary, and higher education was 25.4% (95% CI, 25.0e25.8),
29.1% (95% CI, 28.8e29.5), and 36.6% (95% CI, 36.1e37.2),
respectively. In those aged 35 to 84 years, the majority of study
subjects, myopia prevalence in participants with higher education
was approximately double those with primary education (Fig 3).
For example, in subjects aged 45 to 49 years when tested, the
myopia prevalence was 26.3% (95% CI, 20.1e32.5) comparedfunction of age for 2 birth cohorts (1910e1939, 1940e1979) with 95%
Figure 3. Prevalence of myopia (spherical equivalent 0.75 diopters) with 95% conﬁdence interval stratiﬁed by highest educational level achieved: primary
education, leaving education at age <16 years; secondary education, leaving school at age 19 years; higher education, leaving school at age 20 years.
Williams et al  Increasing Myopia Prevalence and Education in Europewith 51.4% (95% CI, 46.7e56.0) for those with primary and
higher education, respectively, and in those aged 60 to 64 years,
myopia prevalence was 14.0% (95% CI, 12.3e15.8) compared
with 28.7% (95% CI, 25.4e32.0) for those with primary and
higher education, respectively. The trends observed are less clear
in younger subjects (<35 years) in Figure 3, most likely because
of small sample sizes (n ¼ 216 aged 20e25 years, n ¼ 336 aged
25e30 years), which are further stratiﬁed by education level with
corresponding wide CIs.
Levels of education throughout Europe have increased in the
past 90 years (Fig 4). The proportion of individuals progressing to
higher education increased from 4% of those born in the 1900s to
16% in the 1920s, 20% in the 1940s, 33% in the 1960s, and
approximately 61% in the 1980s.
However, although those born more recently were more likely
to have achieved a higher educational level, this alone did not
explain the cohort effect of increasing myopia. As shown in
Figure 5, for individuals aged 45 to 65 years (age range selected forFigure 4. Distribution of highest educational level achieved, stratiﬁed by year of
secondary education, leaving school at age 19 years; higher education, leavinminimal age-related myopia variance and large available sample
size), the increase in myopia prevalence with a more recent birth
decade was observed across all educational groups. This was most
pronounced for participants achieving only a primary education,
in whom myopia prevalence increased from 10.7% (95% CI,
7.6e13.8) to 28.1% (95% CI, 18.1e38.0) between birth decades
1920 to 1929 and 1960 to 1969 (P ¼ 0.001). The corresponding
increase in myopia in those with higher education was from 26.0%
(95% CI, 17.4e34.6) to 40.2% (95% CI, 30.5e50.0) (P ¼ 0.03).
Compared with the reference risk of participants with primary
education and born in the 1920s, the myopia prevalence ratio for
those achieving a higher education was 2.43 (95% CI, 1.26e4.17)
and for those born in the 1960s was 2.62 (95% CI, 1.31e5.00).
Individuals born in the 1960s and completing higher education had
approximately 4 times the baseline risk, with a prevalence ratio of
3.76 (95% CI, 2.21e6.57). Thus, the individual associations of
educational level and birth cohort had an additive effect on myopia
prevalence.birth (1900e1989): primary education, leaving education at age <16 years;
g school at age 20 years.
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Figure 5. Myopia prevalence (spherical equivalent 0.75 diopters) by
birth cohort and educational level in individuals aged 45 to 65 years:
primary education, leaving education at age <16 years; secondary educa-
tion, leaving school at age 19 years; higher education, leaving school at
age 20 years.
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Our study provides the ﬁrst evidence that myopia is
becoming more common across Western and Northern
Europe, with a clear trend of higher myopia prevalence in
participants with a more recent birth year (Fig 1). This is
similar to the increase reported in North America and,
albeit to a lesser extent, Southeast Asian populations.6,7,32,33
Evidence of increasing myopia prevalence carries clinical
and economic implications. The increased requirement for
detection and treatment of myopia, entailing glasses, contact
lenses, or more recently laser refractive surgery, has signiﬁ-
cant implications for clinical optometric and ophthalmic
service provision, and the health care system. Additional
ophthalmic services will be needed for treatable sight-
threatening complications, such as retinal detachment, glau-
coma, and cataract.10,34 The increasing prevalence of myopia
also implies that untreatable complications, such as myopic
maculopathy, most commonly seen in high myopia, will
become more common. This will result in more visual
impairment in middle- to older-aged individuals, including a
proportion of the working-age population, with consequent
economic implications.
Myopia has been strongly associated with educa-
tion,2,21,24,35 and we explored this using a simple 3-tier
classiﬁcation of educational level. Increasing educational
level had a strong effect, with myopia twice as common in
those achieving a higher education compared with partici-
pants leaving school before 16 years of age. There was a
clear trend of increasing prevalence of myopia across the
tiers of education level, suggesting a potential additive effect
of years of education. This interesting association may
reﬂect a number of factors: greater near work activities with
more education and less time in outdoor light, shared ge-
netic factors underlying myopia and intelligence, or factors1494related to educational opportunity, such as socioeconomic
status or maternal nutrition. These associations have been
explored in younger cohorts,18e21,36,37 although causal
pathways are yet to be fully understood.
Reasons for the observed cohort effect are clearly
multifactorial, and education is an obvious possible expla-
nation; in our data, only 12% of participants born in the
1920s went on to higher education, compared with 33%
born in the 1960s. This educational expansion has been
observed across Europe in both men and women, with a
sharp trajectory toward mass higher education after World
War II.28,38 In addition to the disruption of education and
economic consequences of World War II, adverse health
outcomes have been reported in young people growing up at
that time, notably diabetes, depression, and heart disease.39
Although there is no known direct link between these health
issues and myopia, the deprivation may have affected eye
growth and resulting refraction. Certainly there was an
increase in myopia in subjects born after 1950, but it is
difﬁcult to be certain what aspect of the seismic changes
in Europe after the war might be responsible.
Although the younger generations were more educated,
we found a clear increase in the prevalence of myopia across
the birth cohorts within each educational stratum, as well as
the additive effect of educational status. Therefore,
increasing levels of myopia were not explained by education
alone, and a more recent birth year and higher educational
level had an additive effect on myopia risk. Our simple 3-
tier education stratiﬁcation may be subject to residual con-
founding from variation in educational practices, and it may
be these, rather than changes in education level, that are
contributing to the observed cohort effect. In the latter half
of the last century, there was increasing use of computers,
increasing length of the educational day with increased
after-school tuition, and less outdoor play as a result of
reduced recess time.35
Study Limitations
The E3 consortium has provided a large data set to meta-
analyses’ temporal trends and educational associations for
myopia prevalence across Europe. Limitations to this con-
sortium meta-analysis include heterogeneity between studies.
Contributing studies inherently differed in study design and
cohort sampling. In acknowledgment of this heterogeneity,
we performed a random-effect rather than a ﬁxed-effect meta-
analysis, assuming no ﬁxed effect between studies. There are
also differences between European countries in terms of ur-
banization, economy, social class, education, and lifestyle,
which are known to inﬂuence myopia. Data on these vari-
ables at an individual or study-speciﬁc level were not
uniformly available, and data often were collected from
middle-aged and older participants, so retrospective collec-
tion of potential contributing factors such as outdoor expo-
sure, amount of reading, and area of residence during the
critical ﬁrst 20 years of refractive error development would be
impossible. In addition, potential multicollinearity of these
likely highly correlated factors (e.g., reading and education)
would make assessment of separate effects difﬁcult. In an
attempt to reduce heterogeneity arising from these associated
Williams et al  Increasing Myopia Prevalence and Education in Europefactors, we stratiﬁed the random-effects meta-analysis by age
and educational level (both signiﬁcantly associated with
myopia). Applicability of our ﬁndings is greatest for middle-
to older-aged individuals and for those from Northern and
Western European countries, given the sampled ages and the
location of the E3 studies (Table 1), although ultimately the
degree to which these studies are representative of the
underlying population is unknown.
Further limitations include the crude nature in which
education was classed, which as previously acknowledged
may result in residual confounding. In addition, education
status was collected retrospectively and therefore prone to
recall error, possibly heightened in older participants. Re-
fractions were all noncycloplegic, although this is reason-
able given the age of participants.40,41 Finally, these data are
not longitudinal, so we have not examined reasons for the
lower prevalence with age within birth decades, although
the cohort effect we identiﬁed may be part of this expla-
nation. Other reasons include the well-known hyperopic
shift with age and could include other factors, such as
censoring with age if myopic subjects receive earlier cata-
ract surgery.
In conclusion, the prevalence of myopia is increasing in
Europe, a ﬁnding that is not fully explained by increasing
education levels despite higher educational achievement
being associated with myopia and becoming more wide-
spread in Europe. The changes in prevalence are similar to
those observed in North America, although they remain far
less than those identiﬁed in Southeast Asia, possibly
because of differing intensity of education from an early
age.1,6,35 High levels of myopia were detected in the
younger adults with a more recent birth year, of whom
approximately half were affected. This has signiﬁcant im-
plications for the future; increasing myopia prevalence, and
speciﬁcally high levels in younger individuals, will poten-
tially result in an increasing burden of associated visual
impairment in the future.
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